Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| THH | TryHard | $18.47 | -$13.53 | -42.28% | 2M | $1.6B | $4.00$55.05 |
| AGEN | Agenus | $3.69 | -$0.99 | -21.15% | 40K | $159M | $1.38$7.34 |
| SDOT | Sadot Group | $2.57 | -$0.67 | -20.59% | 107.9K | $5.0M | $1.17$35.80 |
| DGNX | Diginex | $2.19 | -$0.47 | -17.68% | 3.1M | $537M | $0.45$39.85 |
| ILAG | Intelligent Living Application Group | $3.26 | -$0.66 | -16.83% | 130.4K | $8.1M | $2.74$9.80 |
| AFJK | Aimei Health Technology | $47.55 | -$9.04 | -15.97% | 14.7K | $346M | $6.75$130.37 |
| OKYO | Okyo Pharma | $2.41 | -$0.42 | -14.84% | 185.1K | $106M | $0.90$3.35 |
| FBYD | Falcon's Beyond Global | $7.36 | -$1.24 | -14.42% | 2.2K | $416M | $3.62$29.02 |
| COYA | Coya Therapeutics | $4.00 | -$0.64 | -13.79% | 673K | $97M | $3.94$8.29 |
| TENX | Tenax Therapeutics | $15.79 | -$2.48 | -13.57% | 6.1K | $114M | $4.63$18.38 |
Related Articles
Featured Article
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
3 Magnificent Growth Stocks to Buy Hand Over Fist
George Budwell, PhD|May 22, 2024
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
George Budwell, PhD|Apr 28, 2024
This small-cap biotech stock is surging. Time to buy?
Advertisement
Down 75%. Is Agenus Stock a Buy on the Dip?
Cory Renauer|Apr 8, 2024
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
George Budwell, PhD|Dec 24, 2023
These two biotech stocks could be poised for a trend reversal.
3 Magnificent Growth Stocks to Buy on the Dip
George Budwell, PhD|Aug 28, 2023
These three biotech stocks are attractive buys right now.
2 Low-Priced Stocks That Could Make You Richer
George Budwell, PhD|Jun 26, 2023
These two low-priced healthcare stocks could skyrocket within the next 12 months.
This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
Jeffrey Little|Oct 2, 2021
Pre-clinical successes lead to exclusive licensing agreements for iBio.
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
Alex Carchidi|Jan 1, 2021
Innovation paid off big for investors.
Is It Too Late to Buy iBio Stock?
Zhiyuan Sun|Oct 29, 2020
The time to make money by investing in iBio is over. Here's why that's good news.
